Alembic Pharmaceuticals Ltd Financial Statement - Alembic Pharmaceuticals Ltd Balance Sheet | Research 360 by Motilal Oswal
15:53 May 24

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals
Up
949.95
-10.60 (-1.10%)
Sector Pharmaceuticals & Biotechnology Industry Pharmaceuticals

Alembic Pharmaceuticals Ltd.

Sector Pharmaceuticals & Biotechnology
Industry Pharmaceuticals
Up
949.95
-10.60 (-1.10%)
15:53 May 24
Quality
image/svg+xml

97/100
High Financial Strength

Valuation
image/svg+xml

45/100
Mid Valuation

Technical

53/100
Technically Neutral

Strength

7

Weakness

1

Opportunity

0

Threats

2

12.78 %

ROE %

9.55 %

ROA %

31.33

EPS

245.12

BVPS

9.88 %

Net Profit Margin

Mar 2020 Mar 2021 Mar 2022 Mar 2023 Mar 2024
Net Sales
4605.75 5393.13 5305.79 5652.62 6228.63
Operating Expenses +
3382.73 3835.58 4431.63 4944.24 5295.28
Raw Material
1249.98 1451.27 1489.61 1630.17 1857.92
Increase Decrease in Cost
-210.59 -193.93 -43.19 78.65 -142.84
Other Manufacturing Expense
17.56 22.39 0 50.9 0
Employee Cost
906.44 1051.17 1133 1169.13 1446.29
Miscellaneous Expenses
1961.2 2036.52 2573.21 2775.57 3043.73
Operating Profit
1223.02 1557.55 874.16 708.38 933.35
Other Income
4.94 10.02 50.46 2.74 28.31
Depreciation
157.32 183.47 286.78 275.43 272.67
Interest
27.16 16.02 17.73 50.17 56.19
Profit before tax and exceptio..
1043.48 1368.08 620.11 385.52 632.8
Exceptional Items
-43.65 0 0 0 0
PBT
999.83 1368.08 620.11 385.52 632.8
Provision for Taxation
199.18 253.32 104.46 12.61 16
Net Profit
800.65 1114.76 515.65 372.91 616.8
NET Profit after MI
828.82 1178.11 520.94 341.99 615.82
EPS
43.97 60.81 26.5 17.4 31.33
Operating Profit Margin (%)
26.55 28.88 16.48 12.53 14.98
Net Profit Margin (%)
18 21.84 9.82 6.05 9.89

ShareHolding

All Data in Percentage (%)

Mar 24 Dec 23 Sep 23 Jun 23 Mar 23
Promoter 69.60 69.60 69.60 69.60 69.60
FII 4.50 4.50 4.50 4.30 4.60
MF 7.80 7.70 7.30 6.60 6.50
Public 10.50 11.40 11.70 12.40 12.50
Others 7.60 6.80 6.90 7.10 6.80
Shareholder Shares Holding %

Take your research to the next level.
Login now to unlock Exclusive Features!

Download Our App On: